Inducible promoters tune mutagenic gene expression to balance genetic diversity with genomic stability during directed evolution.
Extracting obstructive Rec1 and Rec2 domains from Cas proteins creates an open architecture that improves polynucleotide accessibility and targeting efficiency.
Cell surface displayed homing endonucleases bypass intracellular expression to eliminate genomic toxicity during high-throughput variant screening.
Reducing androgen receptor expression in leukocytes overcomes androgen-mediated suppression to improve T cell function and antigen presentation.
Fanzor nucleases provide programmable RNA-guided endonuclease activity, expanding genome editing capabilities beyond prokaryotic systems.
A transformation plasmid incorporates homologous recombination sequences and endonuclease target sites to deliver genes into host genomes.
Chemically modified guide RNAs reduce ALAS1 expression with high cutting efficiency while minimizing off-target effects.
Targeting distinct PPO genes minimizes cut-surface browning and extends shelf life without external treatments.
Site-directed mutations lower exonuclease activity to prevent primer degradation while maintaining high fidelity during DNA amplification.
CGR2 and CGR3 enzyme overexpression modifies pectin methylesterification to eliminate harsh chemical pretreatment costs.
Variant AAV capsid polypeptides increase transduction efficiency in human skeletal muscle tissue.
Novel enzymatic pathway converts acetyl-CoA to acetone, uncoupling synthesis from butanol production.
Engineered CRISPR proteins use lipidation motifs to anchor to cellular membranes, enabling precise subcellular localization of nuclease activity.
A yeast two-hybrid vector library enables high-throughput screening of deubiquitinating enzyme interactions with target proteins.